Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection-Reference-Cited by-同舟云学术

Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection

Published:2020-06-30 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Antonoglou María Belén,Sánchez Alberti Andrés,Redolfi Daniela María,Bivona Augusto Ernesto,Fernández Lynch María Julieta,Noli Truant Sofía,Sarratea María Belén,Iannantuono López Laura Valeria,Malchiodi Emilio Luis,Fernández Marisa Mariel

Funder

Universidad de Buenos Aires

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. Diagnosis and management of Chagas disease and cardiomyopathy;Ribeiro;Nat Rev Cardiol.,2012

2. Immune evasion strategies of Trypanosoma cruzi;Nardy;J Immunol. Res.,2015

3. Experimental and clinical treatment of Chagas disease: a review;Sales;Am J Trop Med Hyg.,2017

4. Chagas disease cardiomyopathy: current concepts of an old disease;Bilate;Rev Inst Med Trop Sao Paulo,2008

5. Chagas disease in Spain, the United States and other non-endemic countries;Gascon;Acta Trop,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trypanosomiasis;The Diagnosis and Treatment of Protozoan Diseases;2024

2. Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis;Vaccine;2023-08

3. Superantigens, a Paradox of the Immune Response;Toxins;2022-11-18

4. Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions;The Lancet Microbe;2022-09

5. The Case for the Development of a Chagas Disease Vaccine: Why? How? When?;Tropical Medicine and Infectious Disease;2021-01-26